BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19186220)

  • 1. Preparation and in vitro evaluation of mucoadhesion and permeation enhancement of thiolated chitosan-pHEMA core-shell nanoparticles.
    Moghaddam FA; Atyabi F; Dinarvand R
    Nanomedicine; 2009 Jun; 5(2):208-15. PubMed ID: 19186220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models.
    Sandri G; Bonferoni MC; Rossi S; Ferrari F; Gibin S; Zambito Y; Di Colo G; Caramella C
    Eur J Pharm Biopharm; 2007 Jan; 65(1):68-77. PubMed ID: 16962751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiolated nanocarriers for oral delivery of hydrophilic macromolecular drugs.
    Dünnhaupt S; Barthelmes J; Köllner S; Sakloetsakun D; Shahnaz G; Düregger A; Bernkop-Schnürch A
    Carbohydr Polym; 2015 Mar; 117():577-584. PubMed ID: 25498673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles.
    Bravo-Osuna I; Vauthier C; Farabollini A; Palmieri GF; Ponchel G
    Biomaterials; 2007 Apr; 28(13):2233-43. PubMed ID: 17261330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of mucoadhesion and permeation enhancement of polymeric amphiphilic nanoparticles.
    Liu Y; Di Zang H; Kong M; Ma FK; Dang QF; Cheng XJ; Ji QX; Chen XG
    Carbohydr Polym; 2012 Jun; 89(2):453-60. PubMed ID: 24750743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiolated chitosans: influence of various sulfhydryl ligands on permeation-enhancing and P-gp inhibitory properties.
    Sakloetsakun D; Iqbal J; Millotti G; Vetter A; Bernkop-Schnürch A
    Drug Dev Ind Pharm; 2011 Jun; 37(6):648-55. PubMed ID: 21561400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of mucoadhesive polymeric nanoparticulate systems on oral bioavailability of a macromolecular model drug.
    Fabiano A; Piras AM; Uccello-Barretta G; Balzano F; Cesari A; Testai L; Citi V; Zambito Y
    Eur J Pharm Biopharm; 2018 Sep; 130():281-289. PubMed ID: 30006244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological evaluation of buccal penetration enhancement properties of chitosan and trimethyl chitosan.
    Sandri G; Poggi P; Bonferoni MC; Rossi S; Ferrari F; Caramella C
    J Pharm Pharmacol; 2006 Oct; 58(10):1327-36. PubMed ID: 17034655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.
    Huang A; Su Z; Li S; Sun M; Xiao Y; Ping Q; Deng Y
    Drug Deliv; 2014 Aug; 21(5):388-96. PubMed ID: 24188463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioadhesive properties of poly(anhydride) nanoparticles coated with different molecular weights chitosan.
    Llabot JM; Salman H; Millotti G; Bernkop-Schnürch A; Allemandi D; Manuel Irache J
    J Microencapsul; 2011; 28(5):455-63. PubMed ID: 21561241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucoadhesive properties of low molecular weight chitosan- or glycol chitosan- and corresponding thiomer-coated poly(isobutylcyanoacrylate) core-shell nanoparticles.
    Palazzo C; Trapani G; Ponchel G; Trapani A; Vauthier C
    Eur J Pharm Biopharm; 2017 Aug; 117():315-323. PubMed ID: 28455206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell line-dependent cytotoxicity of poly(isobutylcyanoacrylate) nanoparticles coated with chitosan and thiolated chitosan: Insights from cultured human epithelial HeLa, Caco2/TC7 and HT-29/MTX cells.
    Pradines B; Lievin-Le Moal V; Vauthier C; Ponchel G; Loiseau PM; Bouchemal K
    Int J Pharm; 2015 Aug; 491(1-2):17-20. PubMed ID: 26051544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific permeability modulation of intestinal paracellular pathway by chitosan-poly(isobutylcyanoacrylate) core-shell nanoparticles.
    Bravo-Osuna I; Vauthier C; Chacun H; Ponchel G
    Eur J Pharm Biopharm; 2008 Jun; 69(2):436-44. PubMed ID: 18395430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation.
    Fan B; Xing Y; Zheng Y; Sun C; Liang G
    Drug Deliv; 2016; 23(1):238-47. PubMed ID: 24865290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation.
    Saremi S; Atyabi F; Akhlaghi SP; Ostad SN; Dinarvand R
    Int J Nanomedicine; 2011 Jan; 6():119-28. PubMed ID: 21289989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Core shell methyl methacrylate chitosan nanoparticles: In vitro mucoadhesion and complement activation.
    Talaei F; Azhdarzadeh M; Hashemi Nasel H; Moosavi M; Foroumadi A; Dinarvand R; Atyabi F
    Daru; 2011; 19(4):257-65. PubMed ID: 22615666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The counterbalanced effect of size and surface properties of chitosan-coated poly(isobutylcyanoacrylate) nanoparticles on mucoadhesion due to pluronic F68 addition.
    Petit B; Bouchemal K; Vauthier C; Djabourov M; Ponchel G
    Pharm Res; 2012 Apr; 29(4):943-52. PubMed ID: 22146804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa.
    Dünnhaupt S; Barthelmes J; Hombach J; Sakloetsakun D; Arkhipova V; Bernkop-Schnürch A
    Int J Pharm; 2011 Apr; 408(1-2):191-9. PubMed ID: 21295123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
    Yin L; Ding J; He C; Cui L; Tang C; Yin C
    Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.